Cargando…
A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007472/ https://www.ncbi.nlm.nih.gov/pubmed/34897632 http://dx.doi.org/10.5603/CJ.a2021.0166 |
_version_ | 1784686856379564032 |
---|---|
author | Ozierański, Krzysztof Tymińska, Agata Marchel, Michal Januszkiewicz, Łukasz Maciejewski, Cezary Główczyńska, Renata Marcolongo, Renzo Caforio, Alida L.P. Wojnicz, Romuald Mizia-Stec, Katarzyna Grzybowski, Jacek Gąsior, Mariusz Nowalany-Kozielska, Ewa Pawlak, Agnieszka Kaczmarek, Krzysztof Żegarska, Jolanta Pączek, Leszek Balsam, Paweł Opolski, Grzegorz Grabowski, Marcin |
author_facet | Ozierański, Krzysztof Tymińska, Agata Marchel, Michal Januszkiewicz, Łukasz Maciejewski, Cezary Główczyńska, Renata Marcolongo, Renzo Caforio, Alida L.P. Wojnicz, Romuald Mizia-Stec, Katarzyna Grzybowski, Jacek Gąsior, Mariusz Nowalany-Kozielska, Ewa Pawlak, Agnieszka Kaczmarek, Krzysztof Żegarska, Jolanta Pączek, Leszek Balsam, Paweł Opolski, Grzegorz Grabowski, Marcin |
author_sort | Ozierański, Krzysztof |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9007472 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Via Medica |
record_format | MEDLINE/PubMed |
spelling | pubmed-90074722022-04-14 A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) Ozierański, Krzysztof Tymińska, Agata Marchel, Michal Januszkiewicz, Łukasz Maciejewski, Cezary Główczyńska, Renata Marcolongo, Renzo Caforio, Alida L.P. Wojnicz, Romuald Mizia-Stec, Katarzyna Grzybowski, Jacek Gąsior, Mariusz Nowalany-Kozielska, Ewa Pawlak, Agnieszka Kaczmarek, Krzysztof Żegarska, Jolanta Pączek, Leszek Balsam, Paweł Opolski, Grzegorz Grabowski, Marcin Cardiol J Clinical Cardiology Via Medica 2022-04-07 /pmc/articles/PMC9007472/ /pubmed/34897632 http://dx.doi.org/10.5603/CJ.a2021.0166 Text en Copyright © 2022 Via Medica https://creativecommons.org/licenses/by-nc-nd/4.0/This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially |
spellingShingle | Clinical Cardiology Ozierański, Krzysztof Tymińska, Agata Marchel, Michal Januszkiewicz, Łukasz Maciejewski, Cezary Główczyńska, Renata Marcolongo, Renzo Caforio, Alida L.P. Wojnicz, Romuald Mizia-Stec, Katarzyna Grzybowski, Jacek Gąsior, Mariusz Nowalany-Kozielska, Ewa Pawlak, Agnieszka Kaczmarek, Krzysztof Żegarska, Jolanta Pączek, Leszek Balsam, Paweł Opolski, Grzegorz Grabowski, Marcin A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) |
title | A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) |
title_full | A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) |
title_fullStr | A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) |
title_full_unstemmed | A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) |
title_short | A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC) |
title_sort | multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus-negative myocarditis or inflammatory cardiomyopathy (improve-mc) |
topic | Clinical Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007472/ https://www.ncbi.nlm.nih.gov/pubmed/34897632 http://dx.doi.org/10.5603/CJ.a2021.0166 |
work_keys_str_mv | AT ozieranskikrzysztof amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT tyminskaagata amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT marchelmichal amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT januszkiewiczłukasz amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT maciejewskicezary amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT głowczynskarenata amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT marcolongorenzo amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT caforioalidalp amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT wojniczromuald amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT miziasteckatarzyna amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT grzybowskijacek amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT gasiormariusz amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT nowalanykozielskaewa amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT pawlakagnieszka amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT kaczmarekkrzysztof amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT zegarskajolanta amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT paczekleszek amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT balsampaweł amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT opolskigrzegorz amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT grabowskimarcin amulticenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT ozieranskikrzysztof multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT tyminskaagata multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT marchelmichal multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT januszkiewiczłukasz multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT maciejewskicezary multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT głowczynskarenata multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT marcolongorenzo multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT caforioalidalp multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT wojniczromuald multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT miziasteckatarzyna multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT grzybowskijacek multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT gasiormariusz multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT nowalanykozielskaewa multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT pawlakagnieszka multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT kaczmarekkrzysztof multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT zegarskajolanta multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT paczekleszek multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT balsampaweł multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT opolskigrzegorz multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc AT grabowskimarcin multicenterrandomizeddoubleblindplacebocontrolledstudytoevaluatetheefficacyofimmunosuppressioninbiopsyprovenvirusnegativemyocarditisorinflammatorycardiomyopathyimprovemc |